Controlling DNA Repair with I-SceI Fusion Proteins
Author Information
Author(s): Hartlerode Andrea, Odate Shobu, Shim Inbo, Brown Jenifer, Scully Ralph
Primary Institution: Department of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America
Hypothesis
BRCA1 regulates homologous recombination during the S phase of the cell cycle.
Conclusion
The study demonstrates that I-SceI-induced homologous recombination is strongly correlated with the percentage of cells in the S phase.
Supporting Evidence
- I-SceI-induced homologous recombination showed a strong positive correlation with the percentage of cells in S phase.
- Acute depletion of BRCA1 disrupted the relationship between S phase fraction and I-SceI-induced homologous recombination.
- The study developed a stably expressed I-SceI fusion protein for precise temporal control of I-SceI activation.
Takeaway
This research shows how a special protein can help scientists control DNA repair in cells, especially during a specific part of the cell cycle.
Methodology
The study involved creating I-SceI fusion proteins and analyzing their effects on homologous recombination in synchronized cell cultures.
Limitations
The synchronization of cell cycles is not absolute, and the effects of I-SceI activation may vary over time.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website